Company intelligence / Profile preview

Tofflon

Ownership: Private
Employees: ~5800
Development stage: Other

Overview

Tofflon delivers comprehensive pharmaceutical and bioprocessing equipment and integrated system solutions globally. It supports the full drug lifecycle with advanced technologies in cell & gene therapy production, monoclonal antibody manufacturing platforms, single-use systems, lyophilization systems, bio-separation technologies, fermentation/bioreactor systems, filling lines for injectables (liquid/lyo), filtration/chromatography units and more. The company has supplied over 12,000 pieces of equipment to more than 3,000 pharmaceutical companies in over 50 countries[5][6][7].

Modalities: Cell therapyGene therapyMonoclonal antibodyBiologicSmall moleculeVaccine
Industry: Non-Drug Biotech

Partnerships

Sinovac Biotech Ltd.PT Bio FarmaItema Group

Beyond the preview

Go deeper on Tofflon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tofflon.

Explore the full profile